The following information is based on a press release from Medivir AB (Medivir) dated November 20, 2014 and may be subject to change.
Medivir´s Extraordinary General Meeting (EGM) held on November 20, 2014 approved a decrease in share capital in form of a voluntary redemption with cash repayment to the shareholders. The board of Medivir has the authorization to determine the final conditions which are yet to be decided. The scheduled Ex-date is February 6, 2015.
NASDAQ OMX Derivatives Markets will carry out a re-calculation of options, forwards and futures in Medivir (MVIR).
For further information, please see the attached file.